GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medx Health Corp (OTCPK:MDXHF) » Definitions » EV-to-FCF

MDXHF (Medx Health) EV-to-FCF : -8.76 (As of Mar. 24, 2025)


View and export this data going back to 2013. Start your Free Trial

What is Medx Health EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Medx Health's Enterprise Value is $16.34 Mil. Medx Health's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was $-1.86 Mil. Therefore, Medx Health's EV-to-FCF for today is -8.76.

The historical rank and industry rank for Medx Health's EV-to-FCF or its related term are showing as below:

MDXHF' s EV-to-FCF Range Over the Past 10 Years
Min: -45.73   Med: -8.92   Max: -3.01
Current: -9.25

During the past 13 years, the highest EV-to-FCF of Medx Health was -3.01. The lowest was -45.73. And the median was -8.92.

MDXHF's EV-to-FCF is ranked worse than
100% of 382 companies
in the Medical Devices & Instruments industry
Industry Median: 27.355 vs MDXHF: -9.25

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-03-24), Medx Health's stock price is $0.0008. Medx Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.008. Therefore, Medx Health's PE Ratio (TTM) for today is At Loss.


Medx Health EV-to-FCF Historical Data

The historical data trend for Medx Health's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medx Health EV-to-FCF Chart

Medx Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -14.62 -7.25 -3.79 -4.03 -6.26

Medx Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.72 -6.26 -9.75 -10.32 -9.25

Competitive Comparison of Medx Health's EV-to-FCF

For the Medical Devices subindustry, Medx Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medx Health's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medx Health's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Medx Health's EV-to-FCF falls into.



Medx Health EV-to-FCF Calculation

Medx Health's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=16.335/-1.864
=-8.76

Medx Health's current Enterprise Value is $16.34 Mil.
Medx Health's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medx Health  (OTCPK:MDXHF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Medx Health's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0008/-0.008
=At Loss

Medx Health's share price for today is $0.0008.
Medx Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.008.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Medx Health EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Medx Health's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Medx Health Business Description

Traded in Other Exchanges
Address
1495 Bonhill Road, Unit 1, Mississauga, ON, CAN, L5T 1M2
Medx Health Corp is engaged in the development, manufacturing, and marketing of skin-related screening tools and phototherapy devices for pain relief and tissue repair. Its two main product lines are; SIAscopy, a medical device technology that is used to scan skin for suspicious moles and lesions; and Phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide effective treatment of pain and tissue damage in the rehabilitation market. It derives key revenue from the sale of Phototherapeutic lasers. The company sells its products internationally, of which prime revenue is generated in Canada and the United States.